No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
- PMID: 32079536
- PMCID: PMC7033922
- DOI: 10.1186/s13054-020-2775-0
No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
Conflict of interest statement
The authors declare to have no competing interests.
Comment on
-
Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.Crit Care. 2018 Dec 17;22(1):341. doi: 10.1186/s13054-018-2278-4. Crit Care. 2018. PMID: 30558639 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
